Tokyo Tape
Sign in
← Nxera Pharma

Annual report

4565.TEDINET S100VHAJ
Period2024-01-01 → 2024-12-31
Filed2025-03-26
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 144
MetricValuePeriodScopeSource row
Revenue¥28.8bn2024-01-01 → 2024-12-31Cons.Revenue IFRS
Revenue¥12.8bn2023-01-01 → 2023-12-31Cons.Revenue IFRS
Revenue¥15.6bn2022-01-01 → 2022-12-31dCons.Revenue IFRS (5-year summary)
Revenue¥17.7bn2021-01-01 → 2021-12-31dCons.Revenue IFRS (5-year summary)
Revenue¥8.8bn2020-01-01 → 2020-12-31dCons.Revenue IFRS (5-year summary)
Operating income−¥5.4bn2024-01-01 → 2024-12-31Cons.Operating profit loss IFRS
Operating income−¥9.5bn2023-01-01 → 2023-12-31Cons.Operating profit loss IFRS
Profit before tax−¥4.7bn2024-01-01 → 2024-12-31Cons.Profit loss before tax IFRS
Profit before tax−¥10.7bn2023-01-01 → 2023-12-31Cons.Profit loss before tax IFRS
Profit before tax¥1.1bn2022-01-01 → 2022-12-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥433m2021-01-01 → 2021-12-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥1.6bn2020-01-01 → 2020-12-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)−¥4.8bn2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥7.2bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥382m2022-01-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥1.0bn2021-01-01 → 2021-12-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥1.5bn2020-01-01 → 2020-12-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income−¥4.8bn2024-01-01 → 2024-12-31Cons.Profit loss IFRS
Net income−¥7.2bn2023-01-01 → 2023-12-31Cons.Profit loss IFRS
Total assets¥151.5bnat 2024-12-31Cons.Assets IFRS
Total assets¥157.2bnat 2023-12-31Cons.Assets IFRS
Total assets¥99.4bnat 2022-12-31dCons.Total assets IFRS (5-year summary)
Total assets¥97.0bnat 2021-12-31dCons.Total assets IFRS (5-year summary)
Total assets¥76.5bnat 2020-12-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥83.0bnat 2024-12-31Cons.Liabilities IFRS
Total liabilities¥90.4bnat 2023-12-31Cons.Liabilities IFRS
Net assets / equity¥68.5bnat 2024-12-31Cons.Equity IFRS
Net assets / equity¥66.8bnat 2023-12-31Cons.Equity IFRS
Net assets / equity¥57.9bnat 2022-12-31dCons.Equity IFRS
Equity (owners)¥68.5bnat 2024-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥66.8bnat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥57.9bnat 2022-12-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥57.5bnat 2021-12-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥52.4bnat 2020-12-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥32.3bnat 2024-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥49.1bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥66.6bnat 2022-12-31dCons.Cash and cash equivalents IFRS
Cash & equivalents¥60.1bnat 2021-12-31dCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥40.0bnat 2020-12-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow−¥7.7bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow−¥5.3bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥10.0bn2022-01-01 → 2022-12-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥7.1bn2021-01-01 → 2021-12-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥4.7bn2020-01-01 → 2020-12-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥4.8bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥63.8bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥1.0bn2022-01-01 → 2022-12-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow¥278m2021-01-01 → 2021-12-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥150m2020-01-01 → 2020-12-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥6.9bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥48.3bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥4.9bn2022-01-01 → 2022-12-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥11.1bn2021-01-01 → 2021-12-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥20.3bn2020-01-01 → 2020-12-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥-53.922024-01-01 → 2024-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥-87.182023-01-01 → 2023-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥4.682022-01-01 → 2022-12-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥12.532021-01-01 → 2021-12-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥18.772020-01-01 → 2020-12-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-53.922024-01-01 → 2024-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-87.182023-01-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥4.632022-01-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥12.42021-01-01 → 2021-12-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥18.592020-01-01 → 2020-12-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥762.15at 2024-12-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥746.92at 2023-12-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥707.2at 2022-12-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥704.97at 2021-12-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥649.92at 2020-12-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio45.2%at 2024-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio42.5%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio58.3%at 2022-12-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio59.3%at 2021-12-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio68.5%at 2020-12-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE-7.2%2024-01-01 → 2024-12-31Cons.Rate of return on equity IFRS (5-year summary)
ROE-11.5%2023-01-01 → 2023-12-31Cons.Rate of return on equity IFRS (5-year summary)
ROE0.7%2022-01-01 → 2022-12-31dCons.Rate of return on equity IFRS (5-year summary)
ROE1.9%2021-01-01 → 2021-12-31dCons.Rate of return on equity IFRS (5-year summary)
ROE3.0%2020-01-01 → 2020-12-31dCons.Rate of return on equity IFRS (5-year summary)
Employees374at 2024-12-31Cons.Number of employees
Employees350at 2023-12-31Cons.Number of employees
Employees202at 2022-12-31dCons.Number of employees
Employees198at 2021-12-31dCons.Number of employees
Employees190at 2020-12-31dCons.Number of employees
Revenue¥6.6bn2024-01-01 → 2024-12-31StandaloneNet sales
Revenue¥5.0bn2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥1.1bn2022-01-01 → 2022-12-31dStandaloneNet sales (5-year summary)
Revenue¥823m2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥433m2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Operating income−¥4.6bn2024-01-01 → 2024-12-31StandaloneOperating income
Operating income−¥335m2023-01-01 → 2023-12-31StandaloneOperating income
Ordinary income−¥1.5bn2024-01-01 → 2024-12-31StandaloneOrdinary income
Ordinary income−¥3.3bn2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income−¥1.6bn2022-01-01 → 2022-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥4.7bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.4bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥2.2bn2024-01-01 → 2024-12-31StandaloneIncome before income taxes
Profit before tax−¥3.3bn2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Net income¥2.1bn2024-01-01 → 2024-12-31StandaloneProfit loss
Net income−¥3.3bn2023-01-01 → 2023-12-31StandaloneProfit loss
Net income−¥1.5bn2022-01-01 → 2022-12-31dStandaloneNet income loss (5-year summary)
Net income−¥4.3bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income−¥1.3bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Total assets¥136.1bnat 2024-12-31StandaloneAssets
Total assets¥142.0bnat 2023-12-31StandaloneAssets
Total assets¥89.4bnat 2022-12-31dStandaloneTotal assets (5-year summary)
Total assets¥94.3bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥78.9bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥68.1bnat 2024-12-31StandaloneLiabilities
Total liabilities¥76.8bnat 2023-12-31StandaloneLiabilities
Net assets / equity¥68.1bnat 2024-12-31StandaloneNet assets
Net assets / equity¥65.2bnat 2023-12-31StandaloneNet assets
Net assets / equity¥57.5bnat 2022-12-31dStandaloneNet assets
Net assets / equity¥58.5bnat 2021-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥61.5bnat 2020-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥6.4bnat 2024-12-31StandaloneCash and deposits
Cash and deposits¥22.0bnat 2023-12-31StandaloneCash and deposits
EPS (basic)¥23.892024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-39.812023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-18.32022-01-01 → 2022-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-52.472021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-16.622020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥19.632024-01-01 → 2024-12-31StandaloneDiluted earnings per share (5-year summary)
Net assets per share¥754.41at 2024-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥726.29at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥699.45at 2022-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥714.03at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥754.79at 2020-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio49.8%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio45.7%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio64.1%at 2022-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio61.7%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio77.1%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE3.2%2024-01-01 → 2024-12-31StandaloneRate of return on equity (5-year summary)
Shares issued89,902,858at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued89,446,777at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued81,923,230at 2022-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued81,518,316at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued80,596,128at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees58at 2024-12-31StandaloneNumber of employees
Employees41at 2023-12-31StandaloneNumber of employees
Employees32at 2022-12-31dStandaloneNumber of employees
Employees30at 2021-12-31dStandaloneNumber of employees
Employees23at 2020-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 1,390
ItemContextValueUnit
Net assetsCurrentYearInstant_NonConsolidatedMember_TreasuryStockMember-3000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ShareholdersEquityMember67837000000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember-0JPY
Net assetsPrior1YearInstant_NonConsolidatedMember_SubscriptionRightsToSharesMember235000000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember65200000000JPY
Issuance of new sharesCurrentYearDuration_NonConsolidatedMember730000000JPY
Profit lossCurrentYearDuration_NonConsolidatedMember2144000000JPY
Purchase of treasury stockCurrentYearDuration_NonConsolidatedMember-2000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember-15000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_SubscriptionRightsToSharesMember-2000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember-17000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember-15000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_SubscriptionRightsToSharesMember-2000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember2855000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember-15000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_SubscriptionRightsToSharesMember233000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember68055000000JPY
MerchandisePrior1YearInstant_NonConsolidatedMember－JPY
MerchandiseCurrentYearInstant_NonConsolidatedMember906000000JPY
Raw materialsPrior1YearInstant_NonConsolidatedMember－JPY
Raw materialsCurrentYearInstant_NonConsolidatedMember7456000000JPY
Business consignment expenses sgaPrior1YearDuration_NonConsolidatedMember1913000000JPY
Business consignment expenses sgaCurrentYearDuration_NonConsolidatedMember3610000000JPY
Personal expenses sgaPrior1YearDuration_NonConsolidatedMember1633000000JPY
Personal expenses sgaCurrentYearDuration_NonConsolidatedMember2617000000JPY
Depreciation sgaPrior1YearDuration_NonConsolidatedMember622000000JPY
Depreciation sgaCurrentYearDuration_NonConsolidatedMember1403000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2025-03-26
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第35期(自　2024年１月１日　至　2024年12月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)ネクセラファーマ株式会社（旧会社名　そーせいグループ株式会社）
Company name in english cover pageFilingDateInstant
Original text (Japanese)Nxera Pharma Co., Ltd.（旧英訳名　Sosei Group Corporation）
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表執行役社長CEO　クリストファー・カーギル
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都港区赤坂九丁目７番２号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03(5962)5718　(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)執行役副社長CAO　キーラン・ジョンソン
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都港区赤坂九丁目７番２号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03(5962)5718　(代表)
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)執行役副社長CAO　キーラン・ジョンソン
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE00981
Fund codeFilingDateInstant－
Security codeFilingDateInstant45650
Filer name in japaneseFilingDateInstant
Original text (Japanese)ネクセラファーマ株式会社
Filer name in englishFilingDateInstantNxera Pharma Co., Ltd.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2023-12-31pass
balance sheet identityconsolidated 2024-12-31pass
balance sheet identitynon_consolidated 2023-12-31pass
balance sheet identitynon_consolidated 2024-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-12-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass